Medipharm Labs Corp Stock Analysis

Medipharm OTC Stock Analysis Notes

The company has price-to-book ratio of 0.36. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medipharm Labs Corp recorded a loss per share of 0.14. The entity last dividend was issued on the 4th of October 2018. MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada. MEDIPHARM LABS is traded on OTC Exchange in the United States.The quote for Medipharm Labs Corp is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Medipharm Labs Corp contact David Pidduck at 705 719 7425 or learn more at https://www.medipharmlabs.com.

Medipharm Labs Corp Investment Alerts

Medipharm Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.26 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medipharm Labs's market, we take the total number of its shares issued and multiply it by Medipharm Labs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Medipharm Profitablity

The company has Profit Margin (PM) of (2.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.61) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.61.

Technical Drivers

As of the 18th of December 2024, Medipharm Labs secures the Downside Deviation of 3.83, mean deviation of 2.66, and Risk Adjusted Performance of 0.0251. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medipharm Labs Corp, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Medipharm Labs, which can be compared to its peers in the industry. Please verify Medipharm Labs Corp coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if Medipharm Labs Corp is priced some-what accurately, providing market reflects its recent price of 0.0456 per share. As Medipharm Labs Corp appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.

Medipharm Labs Corp Price Movement Analysis

Medipharm Labs Outstanding Bonds

Medipharm Labs Predictive Daily Indicators

Medipharm Labs Forecast Models

Medipharm Labs' time-series forecasting models are one of many Medipharm Labs' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medipharm Labs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Medipharm Labs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medipharm shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Medipharm Labs. By using and applying Medipharm OTC Stock analysis, traders can create a robust methodology for identifying Medipharm entry and exit points for their positions.

When running Medipharm Labs' price analysis, check to measure Medipharm Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medipharm Labs is operating at the current time. Most of Medipharm Labs' value examination focuses on studying past and present price action to predict the probability of Medipharm Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medipharm Labs' price. Additionally, you may evaluate how the addition of Medipharm Labs to your portfolios can decrease your overall portfolio volatility.